title: Practice trends in the diagnosis and management of prostate cancer in the United States.
abstract: OBJECTIVE
  The American Urological Association first commissioned the Gallup Organization of Princeton, New Jersey to conduct a study to assess urologists' practice patterns in 1991.
  
  
  METHODS
  A random sample of 514 American urologists was surveyed by the Gallup Organization regarding practice patterns used in the staging and treatment of prostate cancer. The third annual survey taken during August 1994 asked questions regarding the practice of respondents in their diagnosis and management of prostatic cancer.
  
  
  RESULTS
  The survey revealed that 95% of the respondents would recommend radical prostatectomy for men younger than 70 years with confirmed clinically localized prostate cancer.
  
  
  CONCLUSIONS
  In this patient age group, surprisingly, the survey resulted in some interesting facts: 1) 13% regard hormonal manipulation for early stage cancer appropriate, 2) the respondents used extensive numbers of diagnostic staging studies in the new prostate cancer patient with a prostate specific antigen of less than 10 and 3) despite the obvious increased costs, the majority of patients receiving hormone manipulation were being treated with luteinizing hormone-releasing hormone agonists rather than orchiectomy.
authors.affiliation: Health Policy Survey and Research Committee, American Urological Association, Baltimore, Maryland, USA.
authors.forename: W F
authors.initials: WF
authors.lastname: Gee
authors.forename: H L
authors.initials: HL
authors.lastname: Holtgrewe
authors.forename: P C
authors.initials: PC
authors.lastname: Albertsen
authors.forename: M S
authors.initials: MS
authors.lastname: Litwin
authors.forename: M J
authors.initials: MJ
authors.lastname: Manyak
authors.forename: M P
authors.initials: MP
authors.lastname: O'Leary
authors.forename: M R
authors.initials: MR
authors.lastname: Painter
mesh_terms: D000328:Adult; D000368:Aged; D003558:Cystoscopy; D005485:Flutamide / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009919:Orchiectomy; D010818:Practice Patterns, Physicians'; D011364:Professional Practice; D017430:Prostate-Specific Antigen / Q000032:analysis; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D012955:Societies, Medical; D014481:United States; D014567:Urography; D014572:Urology
chemical_list: D007987:Gonadotropin-Releasing Hormone; D005485:Flutamide; D017430:Prostate-Specific Antigen